GE
61
-3
BDX
56
10
TEL
60
-8
HCP
56
-8
MO
60
-2
TROW
47
-6
WMB
68
2
AME
74
-4
IFF
47
-4
URI
60
-6
CFG
74
2
NVDA
52
-5
CNP
54
10
REGN
38
-2
AMGN
42
-4
WM
74
-5
ICE
59
-3
SYF
86
-6
CMS
60
2
STX
45
-4
GE
61
-3
BDX
56
10
TEL
60
-8
HCP
56
-8
MO
60
-2
TROW
47
-6
WMB
68
2
AME
74
-4
IFF
47
-4
URI
60
-6
CFG
74
2
NVDA
52
-5
CNP
54
10
REGN
38
-2
AMGN
42
-4
WM
74
-5
ICE
59
-3
SYF
86
-6
CMS
60
2
STX
45
-4
Financhill
Back

Hartford US Quality Growth ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
11

HQGO
Hartford US Quality Growth ETF

Last Price:
53.38
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
11
Hartford US Quality Growth ETF (HQGO) is a Sell

Is Hartford US Quality Growth ETF a Buy, Sell or Hold?

  • The current Hartford US Quality Growth ETF [HQGO] share price is $53.38. The Score for HQGO is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • HQGO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HQGO Stock Price Chart

What is Hartford US Quality Growth ETF's stock price today?

  • The Hartford US Quality Growth ETF share price today is $53.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQGO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HQGO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.77 Buy
Relative Strength Index (14 RSI): 72.38 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.6 - 52.82) Buy
Bollinger Bands (100): (47.95 - 51.35) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HQGO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.2 Buy
20-day SMA: 51.77 Buy
50-day SMA: 50.87 Buy
200-day SMA: 47.92 Buy
8-day EMA: 52.98 Buy
20-day EMA: 52.14 Buy
50-day EMA: 51.04 Buy
200-day EMA: 47.87 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Hartford US Quality Growth ETF Earnings Growth & HQGO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Hartford US Quality Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):